Skip to main content
TipRanks
Go Ultimate75% OFF

Ovid Therapeutics (1OT) Q2 2023 Earnings Report

6 Followers

DE:1OT Q2 2023 EPS Results

Actual EPS
-EUR 0.16
Consensus EPS
-EUR 0.19
Beat/Miss
Beat by +EUR 0.02
One Year Ago EPS
-EUR 0.19

DE:1OT Q2 2023 Revenue Results

Actual Revenue
EUR 68.04K
Expected Revenue
EUR 43.55K
Beat/Miss
Beat by +EUR 24.50K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/04/2023
Time
Before Open
Conference Call
Friday, August 4, 2023
DE:1OT Upcoming Earnings

Ovid Therapeutics's next earnings date is estimated for March 15, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:1OT Earnings History

DE:1OT earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 15, 20272026 (Q4)-0.10-0.05――
Nov 10, 20262026 (Q3)-0.08-0.09-0.1541.18% (+0.06)
Aug 13, 20262026 (Q2)-0.10-0.07-0.05-33.33% (-0.02)
May 12, 20262026 (Q1)-0.11-0.11-0.1314.29% (+0.02)
Mar 18, 20262025 (Q4)-0.110.05-0.12146.15% (+0.17)
Nov 12, 20252025 (Q3)-0.14-0.15-0.1815.00% (+0.03)
Aug 13, 20252025 (Q2)-0.14-0.050.11-150.00% (-0.16)
May 13, 20252025 (Q1)-0.13-0.13-0.1517.65% (+0.03)
Mar 11, 20252024 (Q4)-0.15-0.12-0.240.91% (+0.08)
Nov 12, 20242024 (Q3)-0.19-0.18-0.15-25.00% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed